Assura PLC Vesting and sale of restricted shares (7662M)
18 September 2023 - 6:51PM
UK Regulatory
TIDMAGR
RNS Number : 7662M
Assura PLC
18 September 2023
18 September 2023
Assura plc
Vesting and Sale of Restricted Shares
Assura plc ("Assura"), the leading primary care property
investor and developer announces that on 15 September 2023, the
restricted shares referred to below vested for the PDMR listed
below.
The table below shows the number of shares vesting, the number
of shares sold to satisfy income tax and national insurance
liabilities, the number of shares sold and the number of shares
retained following the sales. The award was satisfied from shares
held by the Employee Benefit Trust and no additional shares have
been listed.
Number of Number of shares Additional Number of shares
Shares vesting sold to satisfy shares sold after shares
income tax and sold
national insurance
liabilities
Orla Ball 48,767 22,921 25,846 -
---------------- -------------------- ------------- -----------------
The Remuneration Committee of Assura had agreed that sufficient
restricted shares may be sold to cover the arising income tax and
national insurance liabilities and that Ms Ball could sell the
balance of her restricted shares in full. The relevant market price
for taxation purposes is GBP0.4612 per share.
As a result of the above, the PDMR's shareholding and those of
their connected persons is as follows:
Shareholding on Shareholding
14 S eptember 2023 post exercise
O rla Ball 21,072 21,072
-------------------- ---------------
The Notification of Dealing Form for the PDMRs can be found
below.
This notification is made in accordance with the Market Abuse
Regulation.
Notification of dealing form
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Orla Ball
-------------------------- -------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status General Counsel
-------------------------- -------------------------------------------
b) Initial notification/ Initial notification
Amendment
-------------------------- -------------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction
monitor
-----------------------------------------------------------------------
a) Name Assura plc
-------------------------- -------------------------------------------
b) LEI 21380026T19N2Y52XF72
-------------------------- -------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------
a) Description Ordinary shares of 10 pence each
of the financial
instrument,
type of instrument
Identification
code GB00BVGBWW93
-------------------------- -------------------------------------------
b) Nature of
the transaction Vesting of restricted share awards
under PSP
-------------------------- -------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
GBPNIL GBP 4 8,767
----------
-------------------------- -------------------------------------------
d) Aggregated
information N/A
* Aggregated volume
* Price
-------------------------- -------------------------------------------
e) Date of the 15 September 2023
transaction
-------------------------- -------------------------------------------
f) Place of the XLON
transaction
-------------------------- -------------------------------------------
a) Description Ordinary shares of 10 pence each
of the financial
instrument,
type of instrument
Identification
code GB00BVGBWW93
-------------------------- -------------------------------------------
b) Nature of Sale of shares to satisfy tax and national
the transaction insurance liabilities
-------------------------- -------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
GBP0.4612
GBP 22,921
----------
-------------------------- -------------------------------------------
d) Aggregated Aggregate Aggregate Aggregate
information Price Volume Total
* Aggregated volume GBP0.4612 22,921 GBP10,571.17
GBP
---------- --------------
* Price
-------------------------- -------------------------------------------
e) Date of the 15 September 2023
transaction
-------------------------- -------------------------------------------
f) Place of the XLON
transaction
-------------------------- -------------------------------------------
a) Description Ordinary shares of 10 pence each
of the financial
instrument,
type of instrument
Identification
code GB00BVGBWW93
-------------------------- -------------------------------------------
b) Nature of Sale of shares
the transaction
-------------------------- -------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
GBP0.4612
GBP 25,846
----------
-------------------------- -------------------------------------------
d) Aggregated Aggregate Aggregate Aggregate
information Price Volume Total
* Aggregated volume GBP0.4612 25,846 GBP11,920.18
GBP
---------- --------------
* Price
-------------------------- -------------------------------------------
e) Date of the 15 September 2023
transaction
-------------------------- -------------------------------------------
f) Place of the XLON
transaction
-------------------------- -------------------------------------------
- ENDS -
For more information, please contact:
Assura plc Tel: 0161 515 2043
David Purcell, Investor Relations Email: Investor@assura.co.uk
Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Altrincham, UK - caring for more than 600 primary
healthcare buildings, from which over six million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31
March 2023, Assura's portfolio was valued at GBP2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
* EPRA is a registered trademark of the European Public Real
Estate Association
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHDZGMLRRLGFZG
(END) Dow Jones Newswires
September 18, 2023 04:51 ET (08:51 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2024 to May 2024
Assura (LSE:AGR)
Historical Stock Chart
From May 2023 to May 2024
